Featured Research

from universities, journals, and other organizations

Study attempts to reverse autoimmunity in type 1 diabetes

Date:
August 23, 2012
Source:
Immune Tolerance Network
Summary:
Results from a novel experimental therapy for type 1 diabetes that boosts parts of the healthy immune system were just reported.

Results from a novel experimental therapy for Type 1 diabetes that boosts parts of the healthy immune system are reported August 23 in the scientific journal Diabetes. The trial was led by Carla Greenbaum, MD, Diabetes Research Program director at Benaroya Research Institute at Virginia Mason (BRI), and sponsored by the Immune Tolerance Network (ITN), a clinical trial network funded by the National Institutes of Health. The trial took a unique two-pronged approach to treating Type 1diabetes in newly diagnosed participants. Two drugs were administered in combination. One drug interferes with the immune response that causes Type 1 diabetes while a second drug simultaneously boosted the part of the immune response that usually regulates overactive immune cells.

Related Articles


Over 1 million people in the United States have Type 1 diabetes and the incidence is growing. In this disease, the body's immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. However, at the time of diagnosis with Type 1 diabetes, a small number of beta cells may remain active in many individuals. Since even small amounts of natural insulin production can decrease the long-term effects of diabetes, therapies that attempt to rescue these remaining cells are badly needed.

In the clinical research trial, the combination of the two drugs Proleukin (IL-2) and Rapamune (sirolimus) were administered to see whether the drugs would affect the immune system to halt the autoimmune destruction of the remaining beta cells. The authors of the study describe successful boosting of regulatory components of the immune system in all nine subjects treated in the trial. However, other elements of the immune system also were expanded that were not anticipated. The temporary impairment of beta cell function led the authors to conclude that this drug combination was not having the desired overall effect. Monitoring of the insulin production in the nine subjects indicated that the beta cell preservation goal was not achieved, and the study was therefore stopped. "This study result has been extremely important to scientists looking for ways to stop the immune attack," says Dr. Greenbaum. "Our aim would be to harness the good effects of this therapy while preventing the bad effects." Participants who haven't yet completed the study will continue to be followed.

"The clinical and mechanistic findings from this study can help guide future treatments that boost good immunity," says Gerald Nepom, MD, PhD, Director of ITN. "This was an important clinical trial that will improve the design of subsequent trials to rescue beta cells in Type 1 diabetes."


Story Source:

The above story is based on materials provided by Immune Tolerance Network. Note: Materials may be edited for content and length.


Cite This Page:

Immune Tolerance Network. "Study attempts to reverse autoimmunity in type 1 diabetes." ScienceDaily. ScienceDaily, 23 August 2012. <www.sciencedaily.com/releases/2012/08/120823084625.htm>.
Immune Tolerance Network. (2012, August 23). Study attempts to reverse autoimmunity in type 1 diabetes. ScienceDaily. Retrieved March 4, 2015 from www.sciencedaily.com/releases/2012/08/120823084625.htm
Immune Tolerance Network. "Study attempts to reverse autoimmunity in type 1 diabetes." ScienceDaily. www.sciencedaily.com/releases/2012/08/120823084625.htm (accessed March 4, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, March 4, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Mom Triumphs Over Tragedy, Helps Other Families

Mom Triumphs Over Tragedy, Helps Other Families

AP (Mar. 3, 2015) After her son, Dax, died from a rare form of leukemia, Julie Locke decided to give back to the doctors at St. Jude Children&apos;s Research Hospital who tried to save his life. She raised $1.6M to help other patients and their families. (March 3) Video provided by AP
Powered by NewsLook.com
Looted and Leaking, South Sudan's Oil Wells Pose Health Risk

Looted and Leaking, South Sudan's Oil Wells Pose Health Risk

AFP (Mar. 3, 2015) Thick black puddles and a looted, leaking ruin are all that remain of the Thar Jath oil treatment facility, once a crucial part of South Sudan&apos;s mainstay industry. Duration: 01:13 Video provided by AFP
Powered by NewsLook.com
Woman Convicted of Poisoning Son

Woman Convicted of Poisoning Son

AP (Mar. 3, 2015) A woman who blogged for years about her son&apos;s constant health woes was convicted Monday of poisoning him to death by force-feeding heavy concentrations of sodium through his stomach tube. (March 3) Video provided by AP
Powered by NewsLook.com
Treadmill Test Can Predict Chance Of Death Within A Decade

Treadmill Test Can Predict Chance Of Death Within A Decade

Newsy (Mar. 2, 2015) Johns Hopkins researchers analyzed 58,000 heart stress tests to come up with a formula that predicts a person&apos;s chances of dying in the next decade. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins